Homatropaire (homatropine Hbr)

To produce mydriasis and cycloplegia for refraction in adults, 1 or 2 drops of a 2 or 5% solution may be instilled onto the eye(s) immediately before the procedure and repeated in 5-10 minutes if necessary. In children, the usual dosage to produce mydriasis and cycloplegia for refraction is 1 drop of a 2% solution instilled onto the eye(s) immediately before the procedure and repeated at 10-minute intervals as necessary.

For pupillary dilation in the treatment of acute inflammatory conditions of the uveal tract in adults, the usual dosage is 1 or 2 drops of a 2 or 5% solution instilled onto the eye(s) 2 or 3 times daily, and if necessary, as often as every 3 or 4 hours; in children, the usual dosage is 1 drop of a 2% solution 2 or 3 times daily.

Homatropine hydrobromide is applied topically to the eye in the form of a solution. To minimize drainage into the nose and throat and reduce the risk of absorption and systemic reactions, finger pressure should be applied on the lacrimal sac for 1-2 minutes following topical instillation of the solution.

No dosing information is available for this tab.

There is no enhanced messaging for this drug.

There are no contraindication interactions for this drug.

There are no severe interactions for this drug.

There are no moderate interactions for this drug.

There is no enhanced messaging for this drug.

• Predisposition to glaucoma
• Primary angle-closure glaucoma

• Shallow anterior chamber of eye

There are no moderate contraindications for this drug.

There is no enhanced messaging for this drug.

Rare or Very Rare

• Abdominal distension
• Acute cognitive impairment
• Anticholinergic toxicity
• Behavioral disorders
• Drowsy
• Dry skin
• Fatigue
• Fever
• Flushing
• Hallucinations
• Skin rash
• Slurred speech
• Tachycardia
• Unsteady gait
• Xerostomia

Less Frequent

• Blurred vision
• Eyelid edema
• Ocular irritation
• Photophobia

No enhanced messaging available.

No enhanced messaging available.

No enhanced messaging available.

No enhanced messaging available.

No enhanced messaging available.